| Net Cash Provided by (Used in) Operating Activities |
$20,070,368 |
USD |
5.3% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$51,358,465 |
USD |
139% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
22,293,620 |
shares |
126% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$31,288,097 |
USD |
12047% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$27,569,000 |
USD |
-54% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$66,354 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,743,000 |
USD |
128% |
Q4 2024 |
FY 2025 |
| Deferred Tax Assets, Gross |
$1,743,000 |
USD |
128% |
Q4 2024 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,455,000 |
USD |
220% |
Q4 2024 |
FY 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$340,042,000 |
USD |
119% |
Q4 2025 |
FY 2025 |
| Current Federal Tax Expense (Benefit) |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |